Lufax (LU) Financials

$2.02 +0.04 (+1.76%)

As of 02:22 PM Eastern

Annual Income Statements for Lufax

This table shows Lufax's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	6,235	5,711	-581	1,855	1,086	-101	-757
Consolidated Net Income / (Loss)	6,235	5,711	-581	1,855	1,086	-101	-757
Net Income / (Loss) Continuing Operations	6,235	5,711	-581	1,855	1,086	-101	-757
Total Pre-Tax Income	6,974	6,589	285	2,905	1,693	-12	-548
Total Operating Income	3,905	3,894	-3,187	-2,740	-2,410	-2,168	-1,911
Total Gross Profit	6,296	7,014	754	2,190	818	-184	-719
Total Revenue	5,119	8,018	128	734	1,093	689	529
Operating Revenue	5,181	7,971	69	656	1,092	659	564
Other Revenue	-61	47	59	78	0.78	30	-35
Total Cost of Revenue	-1,177	1,004	-626	-1,456	275	873	1,248
Operating Cost of Revenue	-1,177	1,004	-626	-1,456	275	873	1,248
Total Operating Expenses	2,392	3,120	3,941	4,930	3,228	1,984	1,192
Selling, General & Admin Expense	407	410	458	559	418	331	277
Marketing Expense	1,567	2,144	2,740	2,824	2,286	1,393	741
Other Operating Expenses / (Income)	280	280	276	333	462	256	174
Impairment Charge	137	287	468	1,215	62	4.40	0.00
Total Other Income / (Expense), net	3,069	2,695	3,472	5,645	4,103	2,156	1,363
Interest & Investment Income	1,013	655	1,339	2,400	2,709	1,846	1,687
Other Income / (Expense), net	2,056	2,040	2,133	3,245	1,394	310	-324
Income Tax Expense	738	878	866	1,050	607	89	209
Basic Earnings per Share	$12.65	$12.27	$16.78	$42.66	$2.95	$0.30	($1.14)
Weighted Average Basic Shares Outstanding	-	-	1.23B	1.15B	1.15B	1.15B	1.73B
Diluted Earnings per Share	$12.65	$12.27	$16.65	$40.14	$2.95	$0.30	($1.14)
Weighted Average Diluted Shares Outstanding	-	-	1.23B	1.15B	1.15B	1.15B	1.73B
Weighted Average Basic & Diluted Shares Outstanding	-	-	1.23B	1.15B	1.15B	1.15B	1.73B

No quarterly income statements for Lufax are available.

This table details how cash moves in and out of Lufax's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	1,492	671	4,252	-761	1,937	-1,552	-929
Net Cash From Operating Activities	-134	-72	-177	-136	-176	1,792	249
Net Cash From Continuing Operating Activities	-134	-72	-177	-136	-176	-388	-320
Net Income / (Loss) Continuing Operations	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Changes in Operating Assets and Liabilities, net	-	-	-	-	-	-388	-320
Net Cash From Investing Activities	0.00	0.00	-108	-757	801	-489	366
Net Cash From Continuing Investing Activities	0.00	0.00	-108	-757	801	-492	366
Acquisitions	-	-	-	-	-	0.00	-96
Purchase of Investments	-	0.00	-108	-757	801	-10,085	-8,321
Sale of Property, Plant & Equipment	-	-	-	-	-	1.19	1.32
Sale and/or Maturity of Investments	-	-	-	-	-	9,591	8,781
Net Cash From Financing Activities	1,627	742	4,537	133	1,312	-2,852	-1,546
Net Cash From Continuing Financing Activities	1,627	742	4,537	133	1,312	-980	-1,539
Repayment of Debt	-	-	-	-	-	-2,808	-2,074
Payment of Dividends	-	-	-	-	-	-202	-703
Issuance of Debt	283	645	1,629	1,140	1,312	2,059	1,239
Other Financing Activities, net	-	-	-	-	-	-28	0.00

No quarterly cash flow statements for Lufax are available.

This table presents Lufax's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2019	2020	2021	2022	2023	2024
Period end date	12/31/2019	12/31/2020	1/1/2022	12/31/2022	12/31/2023	12/31/2024
Total Assets	21,469	38,281	56,439	50,885	33,012	27,884
Total Current Assets	7,308	7,130	8,330	6,221	2,925	2,788
Restricted Cash	3,532	3,542	4,853	3,927	1,890	1,936
Accounts Receivable	3,776	3,588	3,476	2,294	1,035	852
Plant, Property, & Equipment, net	0.00	0.00	0.00	0.00	0.00	0.00
Total Noncurrent Assets	14,162	31,151	47,342	44,664	30,083	24,848
Long-Term Investments	62	75	72	5.69	0.37	0.00
Goodwill	1,299	1,391	1,399	1,292	1,255	1,257
Intangible Assets	272	290	141	128	123	131
Noncurrent Deferred & Refundable Income Taxes	431	517	0.00	725	807	928
Other Noncurrent Operating Assets	12,097	28,878	45,729	42,513	27,897	22,532
Total Liabilities & Shareholders' Equity	21,469	38,281	56,439	50,885	33,012	27,884
Total Liabilities	14,557	25,492	41,630	37,303	19,985	16,432
Total Current Liabilities	693	843	1,382	1,860	1,190	1,565
Accounts Payable	693	843	1,382	1,860	1,190	1,026
Customer Deposits	-	-	0.00	0.00	0.00	539
Total Noncurrent Liabilities	13,864	24,648	40,130	35,444	18,610	14,759
Long-Term Debt	1,867	4,301	6,905	7,282	6,264	7,849
Noncurrent Deferred & Payable Income Tax Liabilities	944	1,283	1,289	366	182	153
Other Noncurrent Operating Liabilities	11,053	19,064	31,935	27,796	12,164	6,758
Total Equity & Noncontrolling Interests	6,913	12,789	14,808	13,582	13,027	11,453
Total Preferred & Common Equity	6,898	12,544	14,570	13,347	12,808	11,203
Total Common Equity	6,898	12,544	14,570	13,347	12,808	11,203
Common Stock	0.01	0.01	0.01	0.01	0.01	0.02
Retained Earnings	4,213	6,295	8,493	8,968	8,826	8,055
Treasury Stock	-0.00	-0.00	-873	-818	-795	-773
Other Equity Adjustments	2,684	6,249	6,949	5,197	4,776	3,921
Noncontrolling Interest	15	245	239	235	219	250

No quarterly balance sheets for Lufax are available.

This table displays calculated financial ratios and metrics derived from Lufax's official financial filings.

Metric	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-	-	-	-	-
Revenue Growth	0.00%	56.61%	-98.41%	474.86%	48.65%	-36.78%	-23.24%
EBITDA Growth	0.00%	-0.45%	-117.76%	147.95%	-726.08%	-15.26%	-20.26%
EBIT Growth	0.00%	-0.45%	-117.76%	147.95%	-726.08%	-15.26%	-20.26%
NOPAT Growth	0.00%	-3.34%	92.39%	-126.95%	-84.17%	14.60%	11.87%
Net Income Growth	0.00%	-8.41%	-110.18%	419.24%	-145.06%	-120.70%	-646.82%
EPS Growth	0.00%	-3.00%	35.70%	419.24%	-145.06%	-89.84%	-479.50%
Operating Cash Flow Growth	0.00%	46.63%	-146.94%	23.11%	-29.18%	493.78%	-86.11%
Free Cash Flow Firm Growth	0.00%	0.00%	0.83%	-187.96%	32.19%	1.14%	54.80%
Invested Capital Growth	0.00%	0.00%	159.85%	25.38%	1.67%	4.15%	-2.03%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBIT Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Income Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EPS Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Profitability Metrics	-	-	-	-	-	-	-
Gross Margin	122.99%	87.48%	590.30%	298.33%	92.68%	-24.76%	-135.92%
EBITDA Margin	116.44%	74.01%	-824.93%	68.80%	-289.78%	-528.33%	-422.39%
Operating Margin	76.27%	48.56%	-2,495.32%	-373.17%	-421.79%	-569.79%	-361.20%
EBIT Margin	116.44%	74.01%	-824.93%	68.80%	-289.78%	-528.33%	-422.39%
Profit (Net Income) Margin	121.79%	71.22%	-455.01%	252.68%	-76.59%	-267.38%	-143.04%
Tax Burden Percent	89.41%	86.67%	-203.71%	63.86%	377.52%	104.89%	138.14%
Interest Burden Percent	116.99%	111.04%	-27.08%	575.11%	7.00%	48.25%	24.51%
Effective Tax Rate	10.59%	13.33%	303.71%	36.14%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	130.17%	69.60%	-11.52%	-18.92%	-15.70%	-7.69%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	-140.25%	1,424.40%	251.86%	68.08%	6.63%	3.56%
Return on Net Nonoperating Assets (RNNOA)	0.00%	35.05%	-75.50%	24.96%	13.07%	2.00%	1.50%
Return on Equity (ROE)	0.00%	165.23%	-5.90%	13.43%	-5.85%	-13.70%	-6.18%
Cash Return on Invested Capital (CROIC)	0.00%	-69.83%	-19.24%	-34.05%	-20.58%	-19.77%	-5.63%
Operating Return on Assets (OROA)	0.00%	27.64%	-3.53%	1.07%	-5.90%	-8.68%	-7.34%
Return on Assets (ROA)	0.00%	26.60%	-1.95%	3.91%	-1.56%	-4.39%	-2.49%
Return on Common Equity (ROCE)	0.00%	164.87%	-5.82%	13.20%	-5.75%	-13.47%	-6.06%
Return on Equity Simple (ROE_SIMPLE)	0.00%	82.79%	-4.63%	12.71%	-6.19%	-14.21%	0.00%
Net Operating Profit after Tax (NOPAT)	3,491	3,375	6,493	-1,750	-3,222	-2,752	-1,337
NOPAT Margin	68.20%	42.09%	5,083.30%	-238.30%	-295.25%	-398.85%	-252.84%
Net Nonoperating Expense Percent (NNEP)	0.00%	270.42%	-1,354.80%	-263.39%	-87.00%	-22.32%	-11.25%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-6.93%
Cost of Revenue to Revenue	-22.99%	12.52%	-490.30%	-198.33%	7.32%	124.76%	235.92%
SG&A Expenses to Revenue	7.95%	5.11%	358.32%	76.07%	37.60%	47.05%	52.41%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	46.72%	38.92%	3,085.62%	671.50%	514.48%	545.03%	225.27%
Earnings before Interest and Taxes (EBIT)	5,961	5,934	-1,054	505	-3,163	-3,645	-2,234
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	5,961	5,934	-1,054	505	-3,163	-3,645	-2,234
Valuation Ratios	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.32	0.30	0.18	0.07	0.03	0.24
Price to Tangible Book Value (P/TBV)	0.00	0.41	0.35	0.20	0.08	0.03	0.28
Price to Revenue (P/Rev)	0.43	0.27	29.35	3.56	0.89	0.59	5.18
Price to Earnings (P/E)	0.35	0.38	0.00	1.41	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	60.77%	0.00%	0.00%
Earnings Yield	285.04%	261.06%	0.00%	70.97%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.09	0.35	0.29	0.27	0.30	0.52
Enterprise Value to Revenue (EV/Rev)	0.00	0.06	36.62	6.68	4.24	7.70	16.83
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.08	0.00	9.71	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.08	0.00	9.71	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.14	0.72	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	7.67	35.77
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-
Debt to Equity	0.00	0.27	0.34	0.47	0.53	0.47	0.69
Long-Term Debt to Equity	0.00	0.27	0.34	0.47	0.53	0.47	0.69
Financial Leverage	0.00	-0.25	-0.05	0.10	0.19	0.30	0.42
Leverage Ratio	0.00	3.11	3.03	3.43	3.75	3.12	2.49
Compound Leverage Factor	0.00	3.45	-0.82	19.74	0.26	1.51	0.61
Debt to Total Capital	0.00%	21.27%	25.17%	31.76%	34.63%	32.19%	40.66%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	21.27%	25.17%	31.76%	34.63%	32.19%	40.66%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.17%	1.43%	1.09%	1.10%	1.12%	1.30%
Common Equity to Total Capital	0.00%	78.56%	73.40%	67.16%	64.26%	66.69%	58.04%
Debt to EBITDA	0.00	0.31	-4.08	13.67	-2.30	-1.72	-3.51
Net Debt to EBITDA	0.00	-0.29	-0.65	4.07	-1.09	-1.29	-2.65
Long-Term Debt to EBITDA	0.00	0.31	-4.08	13.67	-2.30	-1.72	-3.51
Debt to NOPAT	0.00	0.55	0.66	-3.95	-2.26	-2.28	-5.87
Net Debt to NOPAT	0.00	-0.51	0.11	-1.17	-1.07	-1.71	-4.42
Long-Term Debt to NOPAT	0.00	0.55	0.66	-3.95	-2.26	-2.28	-5.87
Altman Z-Score	0.00	2.02	0.43	0.44	0.19	0.12	0.31
Noncontrolling Interest Sharing Ratio	0.00%	0.22%	1.32%	1.74%	1.64%	1.67%	1.92%
Liquidity Ratios	-	-	-	-	-	-	-
Current Ratio	0.00	10.55	8.45	5.99	3.46	2.64	1.78
Quick Ratio	0.00	5.45	4.25	2.54	1.29	1.05	0.54
Cash Flow Metrics	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-1,810	-1,795	-5,169	-3,505	-3,465	-980
Operating Cash Flow to CapEx	0.00%	0.00%	0.00%	0.00%	0.00%	12,257.53%	0.00%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-
Asset Turnover	0.00	0.37	0.00	0.02	0.02	0.02	0.02
Accounts Receivable Turnover	0.00	2.12	0.03	0.21	0.38	0.42	0.56
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Accounts Payable Turnover	0.00	1.45	0.00	0.00	0.05	0.63	1.13
Days Sales Outstanding (DSO)	0.00	171.88	10,521.11	1,763.29	968.35	876.07	650.90
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	251.95	0.00	0.00	7,203.58	583.34	324.20
Cash Conversion Cycle (CCC)	0.00	-80.08	10,521.11	1,763.29	-6,235.23	292.73	326.70
Capital & Investment Metrics	-	-	-	-	-	-	-
Invested Capital	0.00	5,185	13,473	16,892	17,175	17,889	17,224
Invested Capital Turnover	0.00	3.09	0.01	0.05	0.06	0.04	0.03
Increase / (Decrease) in Invested Capital	0.00	5,185	8,288	3,420	283	714	-357
Enterprise Value (EV)	0.00	475	4,677	4,904	4,631	5,314	8,902
Market Capitalization	2,188	2,188	3,749	2,614	967	404	2,740
Book Value per Share	$0.00	$39.42	$10.19	$11.86	$11.73	$11.32	$9.77
Tangible Book Value per Share	$0.00	$30.44	$8.82	$10.61	$10.49	$10.12	$8.56
Total Capital	0.00	8,780	17,090	21,743	21,024	19,459	19,301
Total Debt	0.00	1,867	4,301	6,905	7,282	6,264	7,849
Total Long-Term Debt	0.00	1,867	4,301	6,905	7,282	6,264	7,849
Net Debt	0.00	-1,728	683	2,054	3,433	4,694	5,912
Capital Expenditures (CapEx)	0.00	0.00	0.00	0.00	0.00	5.65	-1.32
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	3,083	2,744	2,123	516	45	-714
Debt-free Net Working Capital (DFNWC)	0.00	6,615	6,286	6,902	4,359	1,614	1,222
Net Working Capital (NWC)	0.00	6,615	6,286	6,902	4,359	1,614	1,222
Net Nonoperating Expense (NNE)	-2,744	-2,336	7,074	-3,605	-2,387	-907	-581
Net Nonoperating Obligations (NNO)	0.00	-1,728	683	2,054	3,433	4,694	5,771
Total Depreciation and Amortization (D&A)	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	38.45%	2,148.58%	289.18%	47.29%	6.46%	-134.93%
Debt-free Net Working Capital to Revenue	0.00%	82.50%	4,921.84%	940.04%	399.43%	234.00%	231.09%
Net Working Capital to Revenue	0.00%	82.50%	4,921.84%	940.04%	399.43%	234.00%	231.09%
Earnings Adjustments	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	$67.12	$85.32	$45.60	$2.31	($1.14)
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	307.79M	288.05M	286.50M	1.15B	1.73B
Adjusted Diluted Earnings per Share	$0.00	$0.00	$66.60	$80.28	$45.48	$2.31	($1.14)
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	307.79M	288.05M	286.50M	1.15B	1.73B
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	307.79M	288.05M	286.50M	1.15B	1.73B
Normalized Net Operating Profit after Tax (NOPAT)	3,614	3,623	-1,903	-974	-1,499	-1,497	-1,337
Normalized NOPAT Margin	70.59%	45.19%	-1,490.27%	-132.61%	-137.38%	-216.96%	-252.84%
Pre Tax Income Margin	136.22%	82.18%	223.36%	395.69%	-20.29%	-254.92%	-103.55%
Debt Service Ratios	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	-10.96%	-92.93%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	-10.96%	-92.93%

No quarterly metrics and ratios for Lufax are available.

Financials Breakdown Chart

Frequently Asked Questions About Lufax's Financials

When does Lufax's financial year end?

According to the most recent income statement we have on file, Lufax's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Lufax's net income changed over the last 6 years?

Lufax's net income appears to be on a downward trend, with a most recent value of -$756.63 million in 2024, falling from $6.24 billion in 2018. The previous period was -$101.31 million in 2023. See where experts think Lufax is headed by visiting Lufax's forecast page.

What is Lufax's operating income?

Lufax's total operating income in 2024 was -$1.91 billion, based on the following breakdown:

Total Gross Profit: -$718.98 million
Total Operating Expenses: $1.19 billion

How has Lufax's revenue changed over the last 6 years?

Over the last 6 years, Lufax's total revenue changed from $5.12 billion in 2018 to $528.96 million in 2024, a change of -89.7%.

How much debt does Lufax have?

Lufax's total liabilities were at $16.43 billion at the end of 2024, a 17.8% decrease from 2023, and a 12.9% increase since 2019.

How has Lufax's book value per share changed over the last 6 years?

Over the last 6 years, Lufax's book value per share changed from 0.00 in 2018 to 9.77 in 2024, a change of 977.3%.

Related Companies

Financial statements for NYSE:LU last updated on 2/22/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Lufax (LU) Financials

Financials Breakdown Chart

Frequently Asked Questions About Lufax's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Lufax (LU) Financials

Annual Income Statements for Lufax

Quarterly Income Statements for Lufax

Annual Cash Flow Statements for Lufax

Quarterly Cash Flow Statements for Lufax

Annual Balance Sheets for Lufax

Quarterly Balance Sheets for Lufax

Annual Metrics And Ratios for Lufax

Quarterly Metrics And Ratios for Lufax

Financials Breakdown Chart

Frequently Asked Questions About Lufax's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools